Keyphrases
Remission Induction
55%
Mycophenolate Mofetil
50%
Granulomatosis with Polyangiitis
50%
Family Names
50%
Large-vessel Giant Cell Arteritis
50%
Kidney Biopsy
50%
Primary Sjgren's Syndrome
50%
Pneumocystis Jirovecii
50%
Realist Evaluation
50%
Timely Diagnosis
50%
Vessel Wall Inflammation
50%
Renal Risk Score
50%
Maintenance of Remission
50%
Belimumab
50%
Hypocomplementemia
50%
Systemic Vasculitis
50%
Large-vessel Involvement
33%
Disease Relapse
30%
Infection Risk
25%
IgM Paraprotein
25%
Multisystem
25%
Autoimmune Disease
25%
Neutrophil Degranulation
25%
Immunosuppressive Agents
25%
Significant Risk Factors
25%
Blood Vessels
25%
Cardiovascular Disease
25%
Timely Intervention
25%
Reduced Mortality
25%
Malignancy
25%
Organ Function
25%
Therapeutic Agents
25%
Vasculitis
25%
Birmingham Vasculitis Activity Score
22%
ANCA-associated Glomerulonephritis
16%
Mycophenolic Acid
16%
Martu
16%
Anti-C1q Antibodies
16%
Renal Ultrasound
16%
Cryoglobulins
16%
Tubular Basement Membrane
16%
Renal Insufficiency
16%
Complement Levels
16%
Leg Edema
16%
NZBWF1
16%
Blue Stain
16%
Hematoxylin-eosin Staining
16%
Arthropathy
16%
Plasma Cell Infiltration
16%
Disease Remission
16%
Medicine and Dentistry
Pneumocystis Jirovecii
100%
Vasculitis
100%
Systemic Vasculitis
100%
ANCA Associated Vasculitis
100%
Autoimmune Disease
50%
Glucocorticoid
50%
Disease
50%
Infection
50%
Cancer
50%
Population
50%
Glomerulonephritis
50%
Immunosuppressive Drug
50%
Cardiovascular Disease
50%
Renal Vasculitis
50%
Cohort Analysis
50%
Therapeutic Agent
50%
Seasonal Variation
50%
Renal Biopsy
40%
Granulomatosis with Polyangiitis
40%
Microscopic Polyangiitis
30%
Quality of Life
25%
Disease Severity
20%
Kidney Tubule Basement Membrane
16%
Complement Component C1q Antibody
16%
Leg Edema
16%
Anti-Cardiolipin Antibodies
16%
Cryoglobulin
16%
Complement
16%
Hypocomplementemia
16%
Biopsy Technique
10%
Graft Dysfunction
10%
Myeloblastin
10%
Standardized Incidence Ratio
10%
Creatinine
10%
Glomerular Filtration Rate
10%
Excretion
6%
Patient with Glomerulonephritis
6%
Drug Tolerance
5%
Lymphocyte Surface Marker
5%
CD8+ T Lymphocyte
5%
Sialoadhesin
5%
Immunology and Microbiology
ANCA Associated Vasculitis
100%
Pneumocystis Jiroveci
50%
Mycophenolic Acid
50%
Drug Dose Regimen
50%
Dynamics
50%
Leukocyte
50%
Blood Plasma
50%
Glucocorticoid
50%
NZBxNZW F1 Mouse
50%
Myeloma Protein
37%
Neutrophil
33%
Degranulation
25%
Neutrophil Granulocyte
16%
Serum Protein Electrophoresis
12%
Ureaplasma
12%
Enzyme Chemistry
12%
Surface Area
8%
Glomerulus Filtration
8%
Venous Blood
8%
Tumor Necrosis Factor
8%
Body Surface
8%
Lupus Vulgaris
8%
Adventitia
7%
Maackia
7%
CD43
7%
Sialylation
7%
